1. Home
  2. JAGX vs AREB Comparison

JAGX vs AREB Comparison

Compare JAGX & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • AREB
  • Stock Information
  • Founded
  • JAGX 2013
  • AREB 2014
  • Country
  • JAGX United States
  • AREB United States
  • Employees
  • JAGX N/A
  • AREB N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • JAGX Health Care
  • AREB Industrials
  • Exchange
  • JAGX Nasdaq
  • AREB Nasdaq
  • Market Cap
  • JAGX 3.1M
  • AREB 2.8M
  • IPO Year
  • JAGX N/A
  • AREB N/A
  • Fundamental
  • Price
  • JAGX $4.46
  • AREB $16.51
  • Analyst Decision
  • JAGX
  • AREB
  • Analyst Count
  • JAGX 0
  • AREB 0
  • Target Price
  • JAGX N/A
  • AREB N/A
  • AVG Volume (30 Days)
  • JAGX 40.9K
  • AREB 4.6M
  • Earning Date
  • JAGX 03-31-2025
  • AREB 04-15-2025
  • Dividend Yield
  • JAGX N/A
  • AREB N/A
  • EPS Growth
  • JAGX N/A
  • AREB N/A
  • EPS
  • JAGX N/A
  • AREB N/A
  • Revenue
  • JAGX $11,689,000.00
  • AREB $14,447,104.00
  • Revenue This Year
  • JAGX $18.18
  • AREB $45.19
  • Revenue Next Year
  • JAGX $40.06
  • AREB N/A
  • P/E Ratio
  • JAGX N/A
  • AREB N/A
  • Revenue Growth
  • JAGX 19.75
  • AREB N/A
  • 52 Week Low
  • JAGX $4.40
  • AREB $1.10
  • 52 Week High
  • JAGX $540.00
  • AREB $231.75
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 20.11
  • AREB 43.90
  • Support Level
  • JAGX $4.41
  • AREB $1.10
  • Resistance Level
  • JAGX $4.97
  • AREB $8.45
  • Average True Range (ATR)
  • JAGX 0.74
  • AREB 1.69
  • MACD
  • JAGX 0.22
  • AREB 1.20
  • Stochastic Oscillator
  • JAGX 3.95
  • AREB 70.07

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.

Share on Social Networks: